| ||
| Roche's Tarceva helps lung cancer patients Reuters Roche, the world's largest maker of cancer drugs, said the data showed Tarceva nearly doubled the median progression-free survival of Western patients with a genetically distinct type of advanced non-small cell lung cancer, compared with chemotherapy. ... See all stories on this topic » | ||
| Non-Small Cell Lung Cancer Patients Benefit From Less Toxic Combination Of ... Medical News Today (press release) The standard treatment for patients with advanced non-small cell lung cancer (NSCLC) is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity. Now, Fox Chase Cancer Center researchers ... See all stories on this topic » | ||
| AVEO's Ficlatuzumab In Combination With Gefinitib Well Tolerated In Patients ... TheStreet.com (press release) ... AM EDT AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced results from the Phase 1b portion of its Phase 1b/2 clinical study of ficlatuzumab in combination with gefitinib (Iressa™) in Asian subjects with non-small cell lung cancer (NSCLC). ... See all stories on this topic » | ||
| Do Cell Phones Cause Cancer? 13 Other Possible Carcinogens Huffington Post However additional research suggests drinking at least two cups a day could increase the risk of lung cancer by 14 percent. In spite of well-documented evidence relating the escalating incidence of cancer to a wide range of avoidable carcinogenic ... See all stories on this topic » | ||
| Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat PR Newswire (press release) Syndax also has several studies of entinostat ongoing under a cooperative research and development agreement with the National Cancer Institute including trials in combination with azacitidine in patients with advanced non-small cell lung cancer and ... See all stories on this topic » | ||
| Ex-NH Gov. Walter Peterson dies of cancer at 88 Boston Globe Walter Peterson who was the state's chief executive for four years in the late 1960s and early 1970s has died of lung cancer. The 88-year-old Peterson, who never smoked, found out he had lung cancer this spring and received treatment at ... See all stories on this topic » | ||
| GlobeImmune reports cancer vaccines positive results Pharmaceutical Business Review In the first study, GI-4000, a series of Tarmogen products engineered to express the seven most common KRAS mutations, was administered as a first line therapy to patients with stage I-III non-small cell lung cancer (NSCLC) having a matching KRAS ... See all stories on this topic » | ||
| Investment in Oncology Drug Development Remains Strong as 133 Companies ... PR Newswire (press release) Non-small cell lung cancer was the leading disease type, followed closely by breast cancer. "Notably, trials enrolling multiple hematological cancers and multiple solid tumors came in third and sixth, respectively, among all oncology diseases," ... See all stories on this topic » | ||
| ||
| ASCO spotlight on Yervoy, Zytiga and more FiercePharma ... some new data on treatment of stomach and intestinal tumors, Dow Jones notes. Eli Lilly's Alimta drug is the subject of a maintenance study in advanced non-small cell lung cancer. Plus, Roche will present data on Avastin as an ovarian cancer treatment. See all stories on this topic » | ||
| Scientists a step closer to understanding jaagsiekte disease Farmers Guardian A 'SIGNIFICANT step' has been made in research surrounding ovine pulmonary adenocarcinoma (OPA), also know as sheep lung cancer or jaagsiekte disease. Scientists at the Moredun Research Institute, Edinburgh, have been looking at the disease for many ... See all stories on this topic » | ||
| Tekmira Expands Oncology Pipeline With RNAi Therapeutic Targeting Novel Cancer ... Benzinga WEE1 is a tyrosine kinase that regulates cell cycle progression and the response to DNA damage by its control of a cell cycle checkpoint that precedes entry into cell division. Inhibiting WEE1 increases cancer cell sensitivity to DNA damaging agents ... See all stories on this topic » | ||
| Understanding Cancer Energetics Medical News Today (press release) "In addition to solving the long-standing mystery of the Warburg effect, we also discovered that PKM2 may play a far broader role in promoting cancer progression than has been appreciated before." This study was funded by the National Heart, Lung and ... See all stories on this topic » | ||
| Area native to start cutting-edge cancer treatment Fort Scott Tribune 16 to Nov. 3. During this time, I was told that I would/should start looking for a facility to perform a stem cell transplant," he wrote. "We eventually did a lot of our own research and decided on MD Anderson Cancer Center in Houston. ... See all stories on this topic » |
| ||
| What Is Nonsmall Cell Lung Cancer Form Nonsmall Cell Lung Cancer Form. You can print out this form to help you answer the questions. The TNM of the cancer I have: The stage of the cancer that I ... meds.com/lung/guide/u_nsclcform.html | ||
| Non-Small Cell Lung Cancer Patients Benefit From Less Toxic ... The standard treatment for patients with advanced non-small cell lung cancer is a combination of two old-fashioned cytotoxic chemotherapy drugs. ... www.topix.com/.../non-small-cell-lung-cancer-patients-benefit... | ||
| Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer Links shared publicly online related to Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer. organizedwisdom.com/bloodbased-gene...in...cell.../med |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment